Home
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical trial condition

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Explore clinical trials studying Precursor Cell Lymphoblastic Leukemia-Lymphoma. Study availability and eligibility vary by location and protocol.

1,800 public trials 303 recruiting studies

Refine in advanced search Browse all conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results

Completed

Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other Diseases

NCT00357708

Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +33 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

NCT00027560

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +54 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Reduced Intensity Donor Stem Cell Transplant in Treating Patients With High Risk Acute Lymphocytic Leukemia in Complete Remission

NCT00031655

Conditions: Adult Acute Lymphoblastic Leukemia in Remission, Childhood Acute Lymphoblastic Leukemia in Remission, Hematologic Diseases, +12 more
Locations: Oregon Health and Sciences University Portland, Oregon, United States

Veterans Affairs Puget Sound Healthcare System Seattle, Washington, United States

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia

NCT00513175

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +61 more
Locations: University of California San Francisco San Francisco, California, United States

View Trial Details

Completed

PS-341 in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00004002

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +43 more
Locations: Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

Brigham and Women's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders

NCT00005622

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +56 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

View Trial Details

Completed

Combination Chemotherapy With or Without Amifostine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Disease Undergoing Stem Cell Transplantation

NCT00003143

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +38 more
Locations: Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States

View Trial Details

Completed

Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer

NCT00255749

Conditions: Amyloidosis, Anemia, Blood Protein Disorders, +64 more
Locations: Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States

View Trial Details

Completed

Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer

NCT00296023

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +64 more
Locations: Alta Bates Comprehensive Cancer Center Berkeley, California, United States

UCSF Comprehensive Cancer Center San Francisco, California, United States

View Trial Details

Completed

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

NCT00787761

Conditions: Adenocarcinoma, Blast Crisis, Blood Protein Disorders, +82 more
Locations: Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States

View Trial Details

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Precursor Cell Lymphoblastic Leukemia-Lymphoma trial results

Related conditions